Birth Model vs PeriGen (2026)
Both apply models to labour and delivery and they are aimed at different people in the unit. PeriGen watches the patient, with cleared components for automated fetal heart rate interpretation and labor progress and the only independent validation in this category performed by experts at a federal research institute. Birth Model watches the unit, predicting delivery timing so staffing and flow can be planned, alongside a clinical half the company describes less fully. For a labour and delivery unit the honest sequencing is that PeriGen addresses whether this patient is in trouble and Birth Model addresses whether the unit will have anyone free when they are. Birth Model also holds the best security disclosure on this side of the index despite being the smallest vendor in it, which is worth noting given how many larger competitors publish nothing at all.
- The security disclosure is the best of any vendor on this side of the index and it comes from the smallest company here, with a public trust centre rather than assertions.
- The operational half is a real product: predicting delivery timing to synchronise unit operations, forecast staffing and cut waiting, which is work no obstetric early warning system does.
- The method is covered by granted patents, which is an unusual but genuine route to inspecting how the prediction is produced.
- Its algorithms were validated by experts at a federal research institute rather than by the company or a customer, which is the only independent validation of that kind in obstetrics here.
- The regulatory history is the deepest in the category, with multiple cleared components covering automated fetal heart rate interpretation and labor progress.
- It draws continuously from the fetal monitoring infrastructure the unit already runs rather than requiring new instrumentation.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Birth Model and PeriGen are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Birth Model | PeriGen |
|---|---|---|
| Primary category | Clinical Decision Support | Inpatient Deterioration & Risk Monitoring |
| Headquarters | Baltimore, Maryland | Cary, North Carolina |
| Website | birthmodel.com | perigen.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Birth Model its top capability grade on Security Certifications and Trust Center. Set against PeriGen, Birth Model grades higher on several axes, including Model Supply Chain Disclosure, AI Safety and PHI Stewardship and HIPAA and BAA Posture. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards PeriGen its top capability grade on FDA and Regulatory Status. Set against Birth Model, PeriGen grades higher on several axes, including Clinical and Operational Evidence, FDA and Regulatory Status and Deployment Model and Data Residency. Its thinnest published disclosure sits on Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Birth Model or PeriGen?
On the axes where the AI Health Index separates them, Birth Model grades higher on several axes, including Model Supply Chain Disclosure, AI Safety and PHI Stewardship and HIPAA and BAA Posture, and PeriGen grades higher on several axes, including Clinical and Operational Evidence, FDA and Regulatory Status and Deployment Model and Data Residency. Birth Model leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Birth Model and PeriGen differ most?
The widest separation the AI Health Index records between Birth Model and PeriGen is on Model Supply Chain Disclosure, where Birth Model grades B and PeriGen grades D. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Birth Model and PeriGen grade the same?
The AI Health Index grades Birth Model and PeriGen the same on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Birth Model and PeriGen not disclosed?
At the last review, at least one of Birth Model and PeriGen published thin or absent detail on Model Supply Chain Disclosure. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
The two halves of Birth Model sit differently and should be assessed separately: operational forecasting carries no device question, while anything approaching clinical prediction in labour does, and the company publishes no regulatory position.
Neither vendor publishes subgroup or fairness performance, and obstetrics is the clinical domain where that omission costs most, since maternal outcomes in the United States differ sharply by race and a staffing or escalation model that performs unevenly will direct attention away from the patients already least well served. Neither publishes pricing.